Last reviewed · How we verify
Complicated Urinary Tract Infection due to Acinetobacter
Approved treatments
- Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated Urinary Tract Infection due to Acinetobacter patent landscape — cliff calendar, originator estates, attackable patents
- Complicated Urinary Tract Infection due to Acinetobacter treatment landscape brief
- Complicated Urinary Tract Infection due to Acinetobacter treatment updates RSS
Frequently asked questions about Complicated Urinary Tract Infection due to Acinetobacter
What drugs treat Complicated Urinary Tract Infection due to Acinetobacter?
Tracked treatments include Arikayce Kit.
What is the treatment for Complicated Urinary Tract Infection due to Acinetobacter?
Standard treatment for Complicated Urinary Tract Infection due to Acinetobacter includes Arikayce Kit. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated Urinary Tract Infection due to Acinetobacter patent cliff · Complicated Urinary Tract Infection due to Acinetobacter CI report
- Treatment: Arikayce Kit · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing